1.
Gen Dent
; 61(3): 10-3, 2013.
Article
in English
| MEDLINE
| ID: mdl-23649566
2.
Gen Dent
; 61(2): 8-9, 2013.
Article
in English
| MEDLINE
| ID: mdl-23454312
Subject(s)
Anti-Bacterial Agents/adverse effects , Azithromycin/adverse effects , Cardiovascular Diseases/mortality , Anti-Bacterial Agents/administration & dosage , Azithromycin/administration & dosage , Contraindications , Humans , Long QT Syndrome/complications , Randomized Controlled Trials as Topic , Risk
3.
Gen Dent
; 61(1): 11-3, 2013.
Article
in English
| MEDLINE
| ID: mdl-23302354
Subject(s)
Anti-Obesity Agents/pharmacology , Benzazepines/pharmacology , Drug Approval , Fructose/analogs & derivatives , Phentermine/pharmacology , Anti-Obesity Agents/adverse effects , Benzazepines/adverse effects , Drug Combinations , Fructose/adverse effects , Fructose/pharmacology , Humans , Phentermine/adverse effects , United States , United States Food and Drug Administration
4.
Gen Dent
; 60(6): 454-6, 2012.
Article
in English
| MEDLINE
| ID: mdl-23220298
Subject(s)
Anti-Bacterial Agents/therapeutic use , Anticoagulants/therapeutic use , Antifungal Agents/therapeutic use , Hemorrhage/chemically induced , Warfarin/therapeutic use , Anti-Bacterial Agents/adverse effects , Anticoagulants/adverse effects , Antifungal Agents/adverse effects , Dental Care for Chronically Ill , Drug Interactions , Humans , Risk Factors , Warfarin/adverse effects
5.
Gen Dent
; 60(5): 382-4, 2012.
Article
in English
| MEDLINE
| ID: mdl-23032224
6.
Benefits versus risks of aspirin in cardioprotection: dangers of heart attack after discontinuation.
Gen Dent
; 60(4): 255-8, 2012.
Article
in English
| MEDLINE
| ID: mdl-22782034
Subject(s)
Aspirin/therapeutic use , Cardiotonic Agents/therapeutic use , Cardiovascular Diseases/prevention & control , Fibrinolytic Agents/therapeutic use , Platelet Aggregation Inhibitors/therapeutic use , Advisory Committees , Age Factors , Aged , Aspirin/adverse effects , Cardiotonic Agents/adverse effects , Female , Fibrinolytic Agents/adverse effects , Gastrointestinal Hemorrhage/chemically induced , Heart Arrest/etiology , Humans , Male , Medication Adherence , Middle Aged , Myocardial Infarction/prevention & control , Myocardial Ischemia/etiology , Platelet Aggregation Inhibitors/adverse effects , Preventive Medicine , Risk Assessment , Risk Factors , Sex Factors , Stroke/prevention & control , United States
7.
Gen Dent
; 60(3): 176-8, 2012.
Article
in English
| MEDLINE
| ID: mdl-22623453
Subject(s)
Acetaminophen/therapeutic use , Analgesics, Non-Narcotic/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Dental Care , Ibuprofen/therapeutic use , Nonprescription Drugs/therapeutic use , Pain, Postoperative/drug therapy , Acetaminophen/administration & dosage , Analgesics, Non-Narcotic/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Drug Therapy, Combination , Humans , Ibuprofen/administration & dosage , Pain, Postoperative/prevention & control , Randomized Controlled Trials as Topic , Review Literature as Topic
8.
Gen Dent
; 60(2): 90-2, 2012.
Article
in English
| MEDLINE
| ID: mdl-22414499
9.
Gen Dent
; 60(1): 8-11, 2012.
Article
in English
| MEDLINE
| ID: mdl-22313973
Subject(s)
Anticoagulants/therapeutic use , Platelet Aggregation Inhibitors/therapeutic use , Anticoagulants/adverse effects , Antithrombins/adverse effects , Antithrombins/therapeutic use , Benzimidazoles/adverse effects , Benzimidazoles/therapeutic use , Clinical Trials as Topic , Dabigatran , Dental Care for Chronically Ill , Factor Xa Inhibitors , Humans , Morpholines/adverse effects , Morpholines/therapeutic use , Oral Hemorrhage/prevention & control , Piperazines/adverse effects , Piperazines/therapeutic use , Platelet Aggregation Inhibitors/adverse effects , Prasugrel Hydrochloride , Purinergic P2Y Receptor Antagonists/adverse effects , Purinergic P2Y Receptor Antagonists/therapeutic use , Rivaroxaban , Thiophenes/adverse effects , Thiophenes/therapeutic use , beta-Alanine/adverse effects , beta-Alanine/analogs & derivatives , beta-Alanine/therapeutic use
10.
Gen Dent
; 59(2): 88-90, 2011.
Article
in English
| MEDLINE
| ID: mdl-21903516
11.
Gen Dent
; 59(3): 168-70, 2011.
Article
in English
| MEDLINE
| ID: mdl-21903538
Subject(s)
Analgesics, Opioid/administration & dosage , Dental Caries/etiology , Fentanyl/administration & dosage , Sucrose/adverse effects , Administration, Buccal , Analgesics, Opioid/adverse effects , Chemistry, Pharmaceutical , Chronic Pain/drug therapy , Fentanyl/adverse effects , Humans , Migraine Disorders/drug therapy , Risk Factors , Substance-Related Disorders , Sucrose/administration & dosage , Time Factors
12.
Gen Dent
; 59(4): 250-3, 2011.
Article
in English
| MEDLINE
| ID: mdl-21903562
Subject(s)
Drug Approval , United States Food and Drug Administration , Anti-Bacterial Agents/therapeutic use , Antineoplastic Agents/therapeutic use , Antipruritics/therapeutic use , Antipsychotic Agents/therapeutic use , Antirheumatic Agents/therapeutic use , Antithrombin Proteins/therapeutic use , Bone Density Conservation Agents/therapeutic use , Contraceptives, Oral/therapeutic use , Dupuytren Contracture/drug therapy , Gaucher Disease/drug therapy , Glycogen Storage Disease Type II/drug therapy , Gout Suppressants/therapeutic use , HIV-Associated Lipodystrophy Syndrome/drug therapy , Humans , Hypoglycemic Agents/therapeutic use , Multiple Sclerosis/drug therapy , Neuromuscular Agents/therapeutic use , Potassium Channel Blockers/therapeutic use , Sclerosing Solutions/therapeutic use , United States
13.
Gen Dent
; 59(1): 10-2, 2011.
Article
in English
| MEDLINE
| ID: mdl-21613033
Subject(s)
Antibodies, Monoclonal/adverse effects , Bone Density Conservation Agents/adverse effects , Jaw Diseases/chemically induced , Osteonecrosis/chemically induced , Osteoporosis/prevention & control , RANK Ligand/adverse effects , Aged , Antibodies, Monoclonal/pharmacology , Antibodies, Monoclonal, Humanized , Bone Density Conservation Agents/pharmacology , Denosumab , Female , Humans , Male , Middle Aged , RANK Ligand/pharmacology
14.
Gen Dent
; 59(5): 330-2, 2011.
Article
in English
| MEDLINE
| ID: mdl-22313815
Subject(s)
Antineoplastic Agents/adverse effects , Bisphosphonate-Associated Osteonecrosis of the Jaw/etiology , Bone Density Conservation Agents/adverse effects , Diphosphonates/administration & dosage , Diphosphonates/adverse effects , Imidazoles/administration & dosage , Imidazoles/adverse effects , Adolescent , Adult , Aged , Aged, 80 and over , Antineoplastic Agents/administration & dosage , Bone Density Conservation Agents/administration & dosage , Female , Humans , Injections, Intravenous , Male , Middle Aged , Randomized Controlled Trials as Topic , Young Adult , Zoledronic Acid
15.
Gen Dent
; 59(6): 410-3, 2011.
Article
in English
| MEDLINE
| ID: mdl-22313910
Subject(s)
Angiogenesis Inhibitors/adverse effects , Antibodies, Monoclonal, Humanized/adverse effects , Jaw Diseases/chemically induced , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Antineoplastic Agents/adverse effects , Bevacizumab , Bisphosphonate-Associated Osteonecrosis of the Jaw/etiology , Clinical Trials as Topic , Dental Care for Chronically Ill , Diphosphonates/adverse effects , Drug Synergism , Humans , Osteonecrosis/chemically induced
16.
Gen Dent
; 58(6): 474-7, 2010.
Article
in English
| MEDLINE
| ID: mdl-21062715
17.
Gen Dent
; 58(5): 360-3, 2010.
Article
in English
| MEDLINE
| ID: mdl-20829159
Subject(s)
Pharmacies/statistics & numerical data , Prescription Drugs/therapeutic use , Adrenergic Antagonists/therapeutic use , Analgesics/therapeutic use , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Antidepressive Agents/therapeutic use , Hormones/therapeutic use , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Platelet Aggregation Inhibitors/therapeutic use , Proton Pump Inhibitors/therapeutic use , Tranquilizing Agents/therapeutic use , United States
18.
Gen Dent
; 58(4): 280-4, 2010.
Article
in English
| MEDLINE
| ID: mdl-20591770
19.
Gen Dent
; 58(3): 168-70, 2010.
Article
in English
| MEDLINE
| ID: mdl-20478794
Subject(s)
Anticholesteremic Agents/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Muscular Diseases/prevention & control , Ubiquinone/analogs & derivatives , Dietary Supplements , Electron Transport Chain Complex Proteins/drug effects , Electron Transport Chain Complex Proteins/metabolism , Electron Transport Chain Complex Proteins/therapeutic use , Humans , Muscle, Skeletal/drug effects , Muscle, Skeletal/enzymology , Muscular Diseases/chemically induced , Muscular Diseases/enzymology , Ubiquinone/drug effects , Ubiquinone/metabolism , Ubiquinone/therapeutic use
20.
Gen Dent
; 58(2): 87-90, 2010.
Article
in English
| MEDLINE
| ID: mdl-20236913